PAX7 and facioscapulohumeral muscular dystrophy: Importantly, a lower PAX7 target gene score associates with FSHD clinical outcome correlating with fatty replacement of muscle (T1 positivity on MRI – Fig 3) independently of DUX4 target gene activation.